Amino acid API: L-ornithine-L-Aspartate

Ornithine salts for the treatment of liver disease and nutraceutical applications

Many pharmaceutical products make use of amino acids themselves. More than six decades of experience in amino acids, coupled with market-leading API manufacturing know-how, result in a level of flexibility for our customers that is unique in the industry. LOLA has been used as an API for liver treatment for many years.

What is LOLA?

L-Ornithine-L-Aspartate (LOLA) has been used as an API for liver treatment for many years. Its ability to reduce ammonia levels also makes it ideal as a nutraceutical for the prevention of liver disease – and for sports nutrition, as it enables faster post-workout recovery.

What makes LOLA unique?

  • Our L-Ornithine-L-Aspartate has very low methanol content and endotoxin levels, thanks to our efficient purification process
  • Its high purity means it offers superior stability
  • It has a uniform particle-size distribution, and a superior crystalline structure compared to similar products on the market
  • Effective formulations are available or can be custom-developed on request

Why partner with Evonik?

  • Our backward integration ensures consistently outstanding products and security of supply. Moreover, it allows us to address and comply with evolving regulatory requirements. Evonik is backward-integrated into L-Ornithine and L-Aspartic acid, and also manufactures the L-Ornithine-L-Aspartate salt formation.
  • Although LOLA is available as a standard formulation, we have the capabilities to redesign it to address specific customer needs – and this also applies to delivery forms. Correspondingly, we have effervescent tablets, effervescent granules, fast-melt granules, generic granules and chewable tablets.
  • The experience we have gained from LOLA has opened up new avenues, allowing us to propose other amino acids and derivatives that are effective in their own right. Examples include L-Arginine-Aspartate (to treat and prevent liver disease), L-Ornithine HCl (a successful nutraceutical and curative agent for liver malfunction), and other ornithine derivatives available on request.

Improved L-Ornithine-L-Aspartate (LOLA) formulations

Besides the standard market available formulation, we offer specialized LOLA formulations to suit your needs. This also applies to delivery forms: LOLA is available as effervescent tablets or granules, fast melt or generic granules or as chewable tablets. Watch the below video to see the unique product properties for yourself.

Other active pharmaceutical ingredients

Related topics

Complementary media


Looking for information compiled in one document? Our brochures offer an overview of relevant details in just a few pages.

Customer portal

Visit our onCare platform to access a variety of features and content going beyond what you find on our website. 

Health Care Bulletin

Stay up-to-date on industry trends, new Evonik products and services, scientific updates and upcoming seminars.